patients with cystic fibrosis suffering from pancreatic exocrine insufficiency research hub

Open-label single-arm, multicenter clinical trial to evaluate patient acceptability of a new CREON formulation of Pancreas Powder gastro-resistant pellets in patients with cystic fibrosis suffering from pancreatic exocrine insufficiency.

This study is looking at how much people with Cystic Fibrosis like a new way of taking their Creon medicine. It's assessing things like taste, how easy it is to swallow, and overall convenience, to see if this new version is better.